Pharmaceutical companies crisis management shortcomings.doc

 PAGE \* MERGEFORMAT 3 Pharmaceutical companies crisis management shortcomings Crisis management is a harsh teacher, but often not in class suddenly exams! Many pharmaceutical companies lack the necessary scientific and crisis management mechanisms, including systems, personnel, procedures, etc., which for enterprise risk management system is a “short board.” According to the survey show that in our country, the pharmaceutical companies have a sense of crisis less than 40%. Enterprise Crisis Management study shows that senior management of pharmaceutical companies crisis recognition and crisis management capacity is generally weak, respondents are less crisis ability to identify those who hold 72.7%, moderate ability to identify the crisis accounted for 9%, a higher recognition ability of the crisis were only 18%. This shows that most of the business of crisis management situation is worrying. The main problem performance in: Lack of crisis early warning mechanism. Pharmaceutical companies for the crisis early warning signals, such as sales and profits, financial indicators, human resources cost burden is too heavy, dangerous issues such as responding quickly enough to customers, the industry crisis insensitive. Industry into a pharmaceutical crisis, a crisis can make the sign of the industry, but also other pharmaceutical companies may lead to a crisis in the industry. pharmaceutical industry, other pharmaceutical companies in accordance with the signal, adjust business strategy, you can minimize the damage the crisis or to avoid crisis. Lack of crisis response strategies. Although the causes of the crisis are different types is ever-changing, there is no set solution to maintaining the status quo, but the basic framework of crisis management is pretty much the same. Of a number of pharmaceutical companies in setting up contingency plans for crisis , for staff training, inadequate attention, so once the crisis came, one after another of interlocking ev